Diagnostic Value of Anti-Saccharomyces cerevisiae and Antineutrophil Cytoplasmic Antibodies for Inflammatory Bowel Disease: High Prevalence in Patients with Celiac Disease

[1]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[2]  P. Rutgeerts,et al.  Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[3]  C. Andersson,et al.  Comparative Evaluation of Serologic Tests for Celiac Disease: A European Initiative Toward Standardization , 2000, Journal of pediatric gastroenterology and nutrition.

[4]  E S Lander,et al.  Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. , 2000, American journal of human genetics.

[5]  R. Marzari,et al.  Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease , 2000, American Journal of Gastroenterology.

[6]  L. Elfman,et al.  Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease. , 2000, Journal of pediatric gastroenterology and nutrition.

[7]  L. Greco,et al.  Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. , 1999, Gastroenterology.

[8]  I. Hirata,et al.  Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens , 1999, American Journal of Gastroenterology.

[9]  A. Sauaia,et al.  Serologic testing for inflammatory bowel disease. , 1999, The Journal of pediatrics.

[10]  Parnell,et al.  Review article: coeliac disease and its management , 1999, Alimentary pharmacology & therapeutics.

[11]  R. Barnes,et al.  Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease. , 1999, Journal of clinical pathology.

[12]  P. Limburg,et al.  Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). , 1998, Clinical and experimental immunology.

[13]  S. Targan,et al.  Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. , 1998, Gastroenterology.

[14]  O. Goulet,et al.  Anti-Saccharomyces cerevisiae Mannan Antibodies in Familial Crohn's Disease , 1998, American Journal of Gastroenterology.

[15]  S. Targan,et al.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.

[16]  P. Limburg,et al.  Catalase and alpha‐enolase: two novel granulocyte autoantigens in inflammatory bowel diseases , 1998 .

[17]  G. Corazza,et al.  Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study , 1998, Gut.

[18]  G. Verbeke,et al.  Clustering of increased small intestinal permeability in families with Crohn's disease. , 1997, Gastroenterology.

[19]  G. Bottaro,et al.  Celiac disease and selective immunoglobulin A deficiency. , 1997, The Journal of pediatrics.

[20]  H. Freeman,et al.  Perinuclear antineutrophil cytoplasmic antibodies in collagenous or lymphocytic colitis with or without celiac disease. , 1997, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[21]  D. Schuppan,et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.

[22]  M. Mäki.  Coeliac disease and autoimmunity due to unmasking of cryptic epitopes? , 1996, The Lancet.

[23]  R. Ferrari,et al.  Prevalence of celiac disease in patients with juvenile chronic arthritis. , 1996, The Journal of pediatrics.

[24]  C. Richart,et al.  Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. , 1996, The American journal of gastroenterology.

[25]  S. Carroll,et al.  Anti‐neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders , 1996, Clinical and experimental immunology.

[26]  R. Chapman,et al.  Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. , 1996, Gut.

[27]  A. Ventura,et al.  Coeliac disease and insulin‐dependent diabetes mellitus: a causal association? * , 1995, Acta paediatrica.

[28]  C. Pusey,et al.  Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. , 1995, European journal of gastroenterology & hepatology.

[29]  Pekka Collin,et al.  Autoimmune thyroid disorders and coeliac disease. , 1994, European journal of endocrinology.

[30]  A. Lerner,et al.  Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies , 1994, Clinical and experimental immunology.

[31]  M. Clark,et al.  Endomysial antibody: is it the best screening test for coeliac disease? , 1992, Gut.

[32]  C. Kallenberg,et al.  Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. , 1992, The American journal of medicine.

[33]  C. Higgs.  Anti-neutrophil cytoplasmic antibodies. , 1992, Respiratory medicine.

[34]  C. Holdsworth,et al.  Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. , 1992, Gut.

[35]  M. Mäki,et al.  Selective IgA deficiency and coeliac disease. , 1992, Scandinavian journal of gastroenterology.

[36]  J. Visakorpi,et al.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. , 1990, Archives of disease in childhood.

[37]  G. Holmes,et al.  Malignancy in coeliac disease--effect of a gluten free diet. , 1989, Gut.

[38]  G. Holmes,et al.  Association of coeliac disease and inflammatory bowel disease. , 1980, Gut.

[39]  J. Terwilliger,et al.  Genomewide linkage analysis of celiac disease in Finnish families. , 2002, American journal of human genetics.

[40]  M. Segni,et al.  HLA DQ2 and/or DQ8 Is Associated With Celiac Disease–Specific Autoantibodies To Tissue Transglutaminase in Families With Thyroid Autoimmunity , 2001, American Journal of Gastroenterology.

[41]  D. Schuppan,et al.  Celiac Disease and its Link to Type 1 Diabetes Mellitus , 2001, Journal of pediatric endocrinology & metabolism : JPEM.

[42]  C. Kallenberg,et al.  Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. , 1994, Digestive diseases and sciences.

[43]  L. Forzenigo,et al.  Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. , 1994, Digestion.

[44]  W. Gross,et al.  Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA). , 1993, Advances in experimental medicine and biology.

[45]  M N Marsh,et al.  Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). , 1992, Gastroenterology.

[46]  C. O'Morain,et al.  Criteria of case definition in Crohn's disease and ulcerative colitis. , 1989, Scandinavian journal of gastroenterology. Supplement.

[47]  H. Deeg,et al.  T-cell intestinal lymphoma associated with celiac sprue. , 1986, Annals of internal medicine.